SMA Spinraza Peds Market Size and Forecast The Spinal Muscular Atrophy (SMA) treatment market, where Spinraza (Nusinersen) is a key therapy, was valued at approximately USD 3.0 billion in 2023 for the…
ALS Ionis Market: Size, Forecast, Drivers, and Key Trends
ALS Treatment Market Size and Forecast The global Amyotrophic Lateral Sclerosis (ALS) treatment market size was valued at approximately USD 705.8 million in 2024. This valuation is driven by the severe unmet…
IPF Tipelukast Market: Size, Forecast, Drivers, and Key Trends
IPF Tipelukast Market Size and Forecast Tipelukast, also known as MN-001, is currently an emerging therapeutic agent being developed for Idiopathic Pulmonary Fibrosis (IPF) and other related fibrotic diseases. As an investigational…
Sclero Actemra Market: Size, Forecast, Drivers, and Key Trends
Sclero Actemra Market Size and Forecast Actemra (Tocilizumab), while primarily approved for rheumatoid arthritis and Giant Cell Arteritis, is often discussed in the context of systemic sclerosis (Sclero). The total global Actemra…
CTEPH Opsumit Market: Size, Forecast, Drivers, and Key Trends
CTEPH and Opsumit Market Size and Forecast The Chronic Thromboembolic Pulmonary Hypertension (CTEPH) market is valued at approximately USD 1.51 billion in 2025 and is projected to experience robust growth. This expansion…
PAH Tyvaso DPI Market: Size, Forecast, Drivers, and Key Trends
PAH Tyvaso DPI Market Size and Forecast Tyvaso DPI (treprostinil) is a significant inhaled treatment for Pulmonary Arterial Hypertension (PAH), representing a key product within the overall PAH market. The broader PAH…
PCD Dornase Add Market: Size, Forecast, Drivers, and Key Trends
PCD and Dornase Alpha Market Size and Forecast The Primary Ciliary Dyskinesia (PCD) market size was valued at approximately USD 0.51 billion in 2024. PCD is a rare, inherited disorder characterized by…
AAT A1-PI IV Market: Size, Forecast, Drivers, and Key Trends
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size and Forecast The global market for Alpha-1 Antitrypsin Deficiency Augmentation Therapy (AATD-AT) is substantial, addressing a critical need for patients with this genetic disorder, which…
VWD Alphanate Market: Size, Forecast, Drivers, and Key Trends
VWD Alphanate Market Size and Forecast The Von Willebrand Disease (VWD) treatment market, which includes products like Alphanate, is valued robustly due to the chronic nature of the bleeding disorder. The overall…
Emi Prophylaxis Market: Size, Forecast, Drivers, and Key Trends
Emicizumab Prophylaxis Market Size and Forecast The market for Emicizumab prophylaxis, primarily targeting Hemophilia A with and without factor VIII inhibitors, represents a rapidly expanding segment of the hemophilia treatment landscape. This…